TerminatedPhase 2NCT05517668
Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose
Studying Paracetamol poisoning
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Richard Dart, MD, PhD
- Principal Investigator
- Richard Dart, MD, PhDRocky Mountain Poison and Drug Safety, division of Denver Health and Hospital Authority
- Intervention
- Intravenous infusion of N-acetylcysteine(drug)
- Enrollment
- 29 target
- Eligibility
- 10-99 years · All sexes
- Timeline
- 2022 – 2025
Study locations (1)
- Denver Health and Hospital Authority, Denver, Colorado, United States
Collaborators
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05517668 on ClinicalTrials.govOther trials for Paracetamol poisoning
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06549062Pharmacokinetics and Pharmacodynamics of Intravenous Paracetamol in Morbidly Obese and Non- Obese Patients.University Hospital, Ghent
- RECRUITINGNCT04964310Screening of Susceptibility Genes for APAP Induced Drug Induced LIver Injury in ChiNese Population: a Case-control StudyThe First Affiliated Hospital with Nanjing Medical University